Arş. Gör. ÖZTÜRK ATEŞ

Makaleler 30

1. Efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: multicenter study by Turkish Oncology Group

AKYILDIZ A., GÜLTEKİN M., YİĞİT E., Demir E., Ismayilov R., AHMED M. A., et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , cilt.34, ss.1359-1365, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

2. Effect of hypoxia-inducible factor-1 alpha expression on survival in patients with metastatic cervical squamous cell carcinoma treated with first-line chemotherapy and bevacizumab

YILDIRIM H. Ç., Anik H., ATEŞ ÖZDEMİR D., Ismayilov R., AKYILDIZ A., ÇAYIRÖZ K., et al.

BIOMOLECULES AND BIOMEDICINE , cilt.24, sa.4, ss.998-1003, 2024 (SCI-Expanded, Scopus)

3. Adrenocortical Cancer in the Real World: A Comprehensive Analysis of Clinical Features and Management from the Turkish Oncology Group (TOG)

YAŞAR H. A., AKTAŞ B. Y., Ucar G., SEZGİN GÖKSU S., Bilgetekin I., Cakar B., et al.

Clinical Genitourinary Cancer , cilt.22, sa.3, 2024 (SCI-Expanded, Scopus)

4. Efficacy and safety of bevacizumab in patients with low-grade serous ovarian cancer

Karacin C., Sunar V., Urakci Z., YILMAZ A., Ayhan M., Ersoy M., et al.

Future oncology (London, England) , cilt.20, sa.4, ss.207-214, 2024 (SCI-Expanded, Scopus)

5. Unresectable Hepatocellular Carcinoma and Prognostic Factors of Sorafenib Treatment: A Real-Life Experience

Erol C., Bardakçi M., Hizal M., Kahraman S., Yekedüz E., GÜVEN D. C., et al.

Journal of Oncological Science , cilt.9, sa.2, ss.72-78, 2023 (Scopus, TRDizin)

6. The Prevalence of Systemic Rheumatic Diseases Among Breast Cancer Patients and Its Relationship With Survival

Sunar V., Ates O., Korcali Aslan A., Karakas Y., Altundag M. K.

ARCHIVES OF RHEUMATOLOGY , cilt.34, sa.2, ss.141-147, 2019 (SCI-Expanded, Scopus, TRDizin)

7. The frequency and predictors of persistent amenorrhea in premenopausal women with colorectal cancer who received adjuvant chemotherapy

ŞAHİN T., DİZDAR Ö., Ozdemir N., Zengin N., Ates O., Oksuzoglu B., et al.

ANTI-CANCER DRUGS , cilt.30, sa.3, ss.289-294, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

8. Behcet's disease and breast cancer: A case series study

Karatas F., Sahin S., Aytekin A., Erdem G. U., ATEŞ Ö., Ozisik Y., et al.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.14, sa.6, ss.1184-1190, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

9. Association between androgen receptor status and prognosis in triple negative breast cancer

Sunar V., Dogan H. T., Sarici F., ATEŞ Ö., AKIN S., BAŞPINAR B., et al.

JOURNAL OF BUON , cilt.23, sa.5, ss.1325-1330, 2018 (SCI-Expanded, Scopus)

10. Primary gastric choriocarcinoma

Ates O., Altundag K., Gullu I.

JOURNAL OF BUON , cilt.23, sa.2, ss.534, 2018 (SCI-Expanded, Scopus)

11. Comparison of prognosis and clinical features between synchronous bilateral and unilateral breast cancers

Karakas Y., KERTMEN N., LAÇİN Ş., Aslan A., DEMİR M., ATEŞ Ö., et al.

JOURNAL OF BUON , cilt.22, sa.3, ss.623-627, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

12. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients

Karatas F., Erdem G. U., Sahin S., Aytekin A., YÜCE D., SEVER A. R., et al.

BREAST , cilt.32, ss.237-244, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. The short-term safety of adjuvant paclitaxel plus trastuzumab - A single centre experience

ATEŞ Ö., Sunar V., Aslan A., Karatas F., Sahin S., Altundag K.

JOURNAL OF BUON , cilt.22, sa.2, ss.320-324, 2017 (SCI-Expanded, Scopus)

14. Evaluation of risk factors for the recurrence of colorectal polyps and colorectal cancer

ATEŞ Ö., SİVRİ B., KILIÇKAP S.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.47, sa.5, ss.1370-1376, 2017 (SCI-Expanded, Scopus, TRDizin)

15. Correlation of educational status and clinicopathological characteristics of breast cancer: a single center experience

Sarici F., BABACAN T., Buyukhatipoglu H., Balakan O., SEVER A. R., KERTMEN N., et al.

JOURNAL OF BUON , cilt.21, sa.4, ss.826-831, 2016 (SCI-Expanded, Scopus)

16. Trastuzumab 1-year vs 9-week in early-stage HER2-positive, lymph node negative breast cancer patients

Ozen M., Gunduz M., ATEŞ Ö., BABACAN T., SEVER A. R., AKIN S., et al.

JOURNAL OF BUON , cilt.21, sa.4, ss.799-808, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

17. Left laterality is an independent prognostic factor for metastasis in N3 stage breast cancer

Karatas F., Sahin S., Erdem G. U., ATEŞ Ö., BABACAN T., AKIN S., et al.

JOURNAL OF BUON , cilt.21, sa.4, ss.851-858, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

18. Assessment of psychosocial factors and distress in women having adjuvant endocrine therapy for breast cancer: the relationship among emotional distress and patient and treatment-related factors

ATEŞ Ö., SOYLU C., BABACAN T., Sarici F., KERTMEN N., Allen D., et al.

SPRINGERPLUS , cilt.5, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer

ATEŞ Ö., BABACAN T., KERTMEN N., Sarici F., Cenoli A., AKIN S., et al.

JOURNAL OF BUON , cilt.21, sa.2, ss.375-381, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

20. When should we give aromatase inhibitors for insomnia; early in the day or after dinner?

ATEŞ Ö., Sunar V., SEVER A. R., Altundag K.

JOURNAL OF BUON , cilt.21, sa.2, ss.521, 2016 (SCI-Expanded, Scopus)

21. Primary amyloidosis presenting intrahepatic cholestasis and fulminant hepatic failure

Ates O., KÖSEMEHMETOĞLU K., Guner G., Bayraktar Y.

ITALIAN JOURNAL OF MEDICINE , cilt.10, sa.1, ss.71-73, 2016 (ESCI, Scopus)

22. Primary hepatic Ewing sarcoma: a very infrequent case report

ATEŞ Ö., Basel F. B., Bozdogan N., Aksel B., Oksuzoglu O. B.

ITALIAN JOURNAL OF MEDICINE , cilt.10, sa.1, ss.67-70, 2016 (ESCI, Scopus)

23. Prognostic Factors In Breast Cancer Patients With Hepatic Metastases: Impact Of Molecular Subtype And Local Hepatic Treatment

ATEŞ Ö., GÜVEN D. C., BABACAN T., Sunar V., Sarici F., AKSOY S., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.4, ss.206-214, 2016 (SCI-Expanded, Scopus, TRDizin)

24. Efficacy of capecitabine monotherapy as the first-line treatment of metastatic HER2-negative breast cancer

BABACAN T., Efe O., Hasirci A. S., Demirci F., Buyukhatipoglu H., Balakan O., et al.

TUMORI J , cilt.101, sa.4, ss.418-423, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

25. Chemotherapy might not be beneficial in lymph node-negative, hormone-positive, and HER2-negative breast cancer patients: a long-term retrospective analysis

BABACAN T., Buyukhatipoglu H., Balakan O., KERTMEN N., Suner A., Sarici F., et al.

JOURNAL OF BUON , cilt.20, sa.2, ss.479-486, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

26. Molecular subtypes in patients with inflammatory breast cancer; A single center experience

KERTMEN N., BABACAN T., Keskin O., Solak M., Sarici F., AKIN S., et al.

JOURNAL OF BUON , cilt.20, sa.1, ss.35-39, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

27. A retrospective analysis of adjuvant CAF, AC-T and TAC regimens in triple negative early stage breast cancer

Buyukhatipoglu H., BABACAN T., KERTMEN N., Balakan O., Suner A., ATEŞ Ö., et al.

JOURNAL OF BUON , cilt.20, sa.1, ss.22-27, 2015 (SCI-Expanded, Scopus)

28. Acquired C1 esterase inhibitor deficiency in a marginal zone lymphoma patient treated with rituximab

ATEŞ Ö., Sunar V., BABACAN T., AKIN S., KERTMEN N., Altundag K.

JOURNAL OF BUON , cilt.20, sa.1, ss.349, 2015 (SCI-Expanded, Scopus)

29. The First Line Systemic Chemotherapy in Metastatic Gastric Carcinoma: A Comparison of Docetaxel, Cisplatin and Fluorouracil (DCF) Versus Cisplatin and Fluorouracil (CF); Versus Epirubicin, Cisplatin and Fluorouracil (ECF) Regimens in Clinical Setting

KILIÇKAP S., YALÇIN Ş., ATEŞ Ö., Tekuzman G.

HEPATO-GASTROENTEROLOGY , cilt.58, sa.105, ss.208-212, 2011 (SCI-Expanded, Scopus)

30. Paraneoplastic Encephalitis Associated with Anti-Ma2 Antibodies and Mesothelioma-Like Poorly Differentiated Lung Cancer

Bekircan C. E., Eker A., ATEŞ Ö., Oguz K. K.

TURKISH JOURNAL OF NEUROLOGY , cilt.15, sa.2, ss.98-101, 2009 (ESCI, TRDizin) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 10

1. TRASTUZUMAB KARDİYOTOKSİSİTESİNİ İMMUNGLOBULİN /- STEROİD UYGULAMASI ÖNLEYEBİLİR Mİ?, TAVŞAN MODELİ HAYVAN DENEYİ

KERTMEN N., AKSOY S., ERMİŞ D. Y., KESKİN Ö., SOLAK M., ARIK Z., et al.

22. UKK, Türkiye, 19 - 23 Nisan 2017, (Özet Bildiri)

2. The impact of the total size of lesions in multifocal multicentric breast cancer on survival

Karakaş Y., DİZDAR Ö., Akın S., ATEŞ Ö., ŞENDUR M. A. N., AKSOY S., et al.

2016 ASCO Annual Meeting, 29 Mayıs - 03 Haziran 2016, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

3. Clinicopathologic characteristics of patients with recurrent or metastatic synovial sarcoma

ATEŞ Ö., AKSOY S., YETER H. H., Akın S., KERTMEN N., DİZDAR Ö., et al.

2016 ASCO Annual Meeting, 29 Mayıs - 03 Haziran 2016, (Tam Metin Bildiri)

4. Kadri Altundag Taner Babacan Orhan Efe Ahmet S Hasırcı Fatih Demirci Hakan Buyukhatıpoglu Ozan Balakan Furkan Saim Sarıcı Neyran Kertmen Ece Esin Serkan Akin Ozturk Ates Sercan Aksoy Ali R Sever

ALTUNDAĞ M. K., Babacan T., EFE O., HASIRCI A. S., DEMİRCİ F., BUYUKHATİPOGLU H., et al.

2015 ASCO Annual Meeting, 29 Mayıs - 02 Haziran 2015, (Tam Metin Bildiri)

5. Tumor locations significantly affect disease free survival and overall survival

BUYUKHATİPOGLU H., Babacan T., KERTMEN N., Ateş Ö., AKTAŞ G., ŞENDUR M. A. N., et al.

2015 ASCO Annual Meeting, 29 Mayıs - 02 Haziran 2015, (Tam Metin Bildiri)

6. Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer

Ateş Ö., Babacan T., SARICI F., KERTMEN N., CENOLİ A., Akın S., et al.

ASCO Annual Meeting, 29 Mayıs - 02 Haziran 2015, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

7. Efficacy of capecitabine monotherapy as the first-line treatment of metastatic HER-2 negative breast cancer.

Altundag K., Babacan T., Efe O., Hasirci A. S., Demirci F., Buyukhatipoglu H., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri) Sürdürülebilir Kalkınma